The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABSCI CORPORATION | COM | 00091E109 | 2,615,187 | 998,163 | SH | DFND | 0 | 998,163 | 0 | ||
| ALECTOR INC | COM | 014442107 | 6,701,409 | 3,545,719 | SH | DFND | 0 | 3,545,719 | 0 | ||
| CARISMA THERAPEUTICS INC | COM | 14216R101 | 616,993 | 1,473,240 | SH | DFND | 0 | 1,473,240 | 0 | ||
| ENTRADA THERAPEUTICS INC | COM | 29384C908 | 30,080,589 | 1,739,768 | SH | DFND | 0 | 1,739,768 | 0 | ||
| EVAXION BIOTECH A/S | SPONSORED ADS | 29970R204 | 458,443 | 542,279 | SH | DFND | 0 | 542,279 | 0 | ||
| KYMERA THERAPEUTICS INC | COM | 501575104 | 31,064,198 | 772,165 | SH | DFND | 0 | 772,165 | 0 | ||
| LAVA THERAPEUTICS NV | SHS | N51517105 | 1,093,027 | 1,149,345 | SH | DFND | 0 | 1,149,345 | 0 | ||
| MODERNA INC | COM | 60770K107 | 95,974,540 | 2,308,190 | SH | DFND | 1 | 0 | 2,308,190 | 0 | |
| NEUPHORIA THERAPEUTICS INC | COM | 64136E102 | 34,393 | 10,027 | SH | DFND | 1 | 0 | 10,027 | 0 | |
| PERSONALIS INC | COM | 71535D106 | 81,179,771 | 14,044,943 | SH | DFND | 1 | 0 | 14,044,943 | 0 | |
| SUTRO BIOPHARMA INC | COM | 869367102 | 5,011,257 | 2,723,509 | SH | DFND | 1 | 0 | 2,723,509 | 0 | |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 1,790,746 | 93,414 | SH | DFND | 0 | 93,414 | 0 | ||
| XILIO THERAPEUTICS INC | COM | 98422T100 | 1,416,989 | 1,483,758 | SH | DFND | 0 | 1,483,758 | 0 | ||
